Startups
Edit
Cellogen Therapeutics
https://cellogentherapeutics.com/Last activity: 18.05.2026
Probably Closed
Cellogen therapeutics is developing next generation CAR T-cells and gene manipulation techniques to treat cancers and blood disorders
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 18, 2026 | Kotak Alts' life sciences fund backs gene therapy firm | Credit: 123RF.com Kotak Alternate Asset Managers Ltd has invested in Cellogen Therapeutics, a biotechnology firm focussed on cell and gene therapies. Kotak Alts has invested Rs 20 crore ($2 million) in the biotech firm through its early- to... |
| Cellogen Therapeutics | “Cellogen therapeutics is developing next generation CAR T-cells and gene manipulation techniques to treat cancers and blood disorders ” | |
| Cellogen Therapeutics | “Cellogen Therapeutics The cells of next generation. – Cellogen Therapeutics is biotech startup which is striving today to come up with innovative cell therapy-based solutions for a healthy tomorrow.” |
Reviews 0
FAQ about Cellogen Therapeutics
What has the press written about Cellogen Therapeutics?
Parsers VC has collected 4 articles mentioning Cellogen Therapeutics, among them “Kotak Alts' life sciences fund backs gene therapy firm” (May 18, 2026) and “Cellogen Therapeutics”.
Is Cellogen Therapeutics still active?
Cellogen Therapeutics is probably closed: its latest activity on Parsers VC dates from May 18, 2026.